Opexa Therapeutics, Inc. (OPXA)

[davidsson10]

Seeking Alpha:

Opexa up almost 50%, equity offering coming?

Nano cap Opexa Therapeutics (OPXA +47.7%) jumps on more than triple normal volume. Shares are up 160% since bottoming at $0.50 on November 9 after the Tcelna flop in a multiple sclerosis study.
No particular news accounts for the action, but the company stated in a November 14 press release that its quick assets will only be sufficient to fund operations into Q1. An equity offering could be announced any time.